首页> 外文OA文献 >PCV74 PREDICTED REDUCTION IN HOSPITAL DAYS AND ASSOCIATED COSTS AMONG MANAGED CARE PRIMARY AND SECONDARY RISK MIXED DYSLIPIDEMIA PATIENTS TREATED WITH FIXED DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN COMBINATION THERAPY

【2h】

PCV74 PREDICTED REDUCTION IN HOSPITAL DAYS AND ASSOCIATED COSTS AMONG MANAGED CARE PRIMARY AND SECONDARY RISK MIXED DYSLIPIDEMIA PATIENTS TREATED WITH FIXED DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN COMBINATION THERAPY

机译：固定剂量烟酸延缓释放和辛伐他汀联合治疗引起的PCV74预测的住院日减少和相关的成本，包括可控制的护理初次和二级风险混合型血脂异常患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Simko RJ; Balu S; Webb SF; Quimbo R; Cziraky MJ;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies [J] . Foucher Christelle, Aubonnet Patrick, Reichert Petr, Cardiovascular therapeutics . 2015,第6期

机译：非诺贝特/辛伐他汀疗法的新固定剂量联合治疗可显着改善混合性血脂异常和单药高危患者的血脂水平
2. Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia [J] . Klaus G Parhofer Vascular Health and Risk Management . 2009,第4期

机译：烟酸/拉洛哌特缓释固定组合治疗混合血脂异常和原发性高胆固醇血症的评论
3. Simultaneous Quantification of Simvastatin and Simvastatin Acid in Human Plasma with a Highly Sensitive LC-ESI-MS/MS Method: Application to a Pharmacokinetic Study in Healthy Chinese Volunteers with a Fixed Dose of Simvastatin and Extended-Release Niacin Combination Tablet [J] . Li Qiuying, Yang Yan, Shi Guobing, Current pharmaceutical analysis. . 2016,第2期

机译：高灵敏度LC-ESI-MS / MS方法同时定量测定人血浆中的辛伐他汀和辛伐他汀酸：固定剂量的辛伐他汀和缓释烟酸组合片在健康中国志愿者体内的药代动力学研究中的应用
4. A Predictive Model to Identify Patients at Risk of Unplanned 30-Day Acute Care Hospital Readmission [C] . Lemke Klaus IEEE International Conference on Healthcare Informatics . 2013

机译：识别有计划外30天急性护理医院再次入院风险的患者的预测模型
5. Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter Randomized Trial [O] . Antonio Carlos Amedeo Vattimo, Francisco Antonio Helfestein Fonseca, Douglas Costa Morais, 2020

机译：罗苏伐他汀和欧塞蒂米贝的固定剂量组合的疗效和耐受性与司法素和欧洲血管血症患者的辛伐他汀和欧洲血管血症患者的固定剂量组合相比：多中心随机试验
6. PCV83 AN EVALUATION OF THE INCREMENTAL CHANGE IN THE INCIDENCE OF CARDIOVASCULAR EVENTS AND RELATED COSTS WITH THE ADDITION OF FIXED-DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN THERAPY TO THE MANAGED CARE FORMULARY [O] . Balu S, Simko RJ, Burge RT, 2008

机译：PCV83评价固定剂量烟酸延长释放和辛伐他汀治疗后，心血管事件和相关费用发生率的增加变化

PCV74 PREDICTED REDUCTION IN HOSPITAL DAYS AND ASSOCIATED COSTS AMONG MANAGED CARE PRIMARY AND SECONDARY RISK MIXED DYSLIPIDEMIA PATIENTS TREATED WITH FIXED DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN COMBINATION THERAPY

著录项

相似文献

相关主题

期刊订阅